BRPI0812253A2 - Derivados de prolinamida-tetrazol como antagonistas do receptor nk-3 - Google Patents
Derivados de prolinamida-tetrazol como antagonistas do receptor nk-3Info
- Publication number
- BRPI0812253A2 BRPI0812253A2 BRPI0812253-9A2A BRPI0812253A BRPI0812253A2 BR PI0812253 A2 BRPI0812253 A2 BR PI0812253A2 BR PI0812253 A BRPI0812253 A BR PI0812253A BR PI0812253 A2 BRPI0812253 A2 BR PI0812253A2
- Authority
- BR
- Brazil
- Prior art keywords
- receptor antagonists
- prolinamide
- tetrazol
- derivatives
- tetrazol derivatives
- Prior art date
Links
- 239000002464 receptor antagonist Substances 0.000 title abstract 2
- 229940044551 receptor antagonist Drugs 0.000 title abstract 2
- 102000002003 Neurokinin-3 Receptors Human genes 0.000 title 1
- 108010040716 Neurokinin-3 Receptors Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 101001125071 Homo sapiens Neuromedin-K receptor Proteins 0.000 abstract 1
- 102100029409 Neuromedin-K receptor Human genes 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07109783 | 2007-06-07 | ||
| PCT/EP2008/056587 WO2008148688A1 (en) | 2007-06-07 | 2008-05-29 | Prolinamide-tetrazole derivatives as nk3 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0812253A2 true BRPI0812253A2 (pt) | 2014-12-23 |
Family
ID=39768738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0812253-9A2A BRPI0812253A2 (pt) | 2007-06-07 | 2008-05-29 | Derivados de prolinamida-tetrazol como antagonistas do receptor nk-3 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7501422B2 (pt) |
| EP (1) | EP2155729B1 (pt) |
| JP (1) | JP2010529068A (pt) |
| KR (1) | KR101163294B1 (pt) |
| CN (1) | CN101679385A (pt) |
| AT (1) | ATE498622T1 (pt) |
| AU (1) | AU2008258664B2 (pt) |
| BR (1) | BRPI0812253A2 (pt) |
| CA (1) | CA2690292A1 (pt) |
| DE (1) | DE602008005014D1 (pt) |
| ES (1) | ES2359598T3 (pt) |
| IL (1) | IL202282A0 (pt) |
| MX (1) | MX2009013116A (pt) |
| WO (1) | WO2008148688A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023042914A1 (en) * | 2021-09-17 | 2023-03-23 | Otsuka Pharmaceutical Co., Ltd. | Pyrrolidine compounds as histone deacetylase inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040034019A1 (en) * | 2002-08-08 | 2004-02-19 | Ronald Tomlinson | Piperazine and piperidine derivatives |
-
2008
- 2008-05-29 CN CN200880018987A patent/CN101679385A/zh active Pending
- 2008-05-29 JP JP2010510746A patent/JP2010529068A/ja not_active Ceased
- 2008-05-29 BR BRPI0812253-9A2A patent/BRPI0812253A2/pt not_active IP Right Cessation
- 2008-05-29 MX MX2009013116A patent/MX2009013116A/es active IP Right Grant
- 2008-05-29 ES ES08760179T patent/ES2359598T3/es active Active
- 2008-05-29 KR KR1020107000225A patent/KR101163294B1/ko not_active IP Right Cessation
- 2008-05-29 CA CA2690292A patent/CA2690292A1/en not_active Abandoned
- 2008-05-29 AU AU2008258664A patent/AU2008258664B2/en not_active Ceased
- 2008-05-29 DE DE602008005014T patent/DE602008005014D1/de active Active
- 2008-05-29 WO PCT/EP2008/056587 patent/WO2008148688A1/en active Application Filing
- 2008-05-29 EP EP08760179A patent/EP2155729B1/en not_active Not-in-force
- 2008-05-29 AT AT08760179T patent/ATE498622T1/de active
- 2008-05-30 US US12/129,720 patent/US7501422B2/en not_active Expired - Fee Related
-
2009
- 2009-11-23 IL IL202282A patent/IL202282A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL202282A0 (en) | 2010-06-16 |
| AU2008258664B2 (en) | 2012-07-05 |
| US20080306089A1 (en) | 2008-12-11 |
| DE602008005014D1 (de) | 2011-03-31 |
| EP2155729A1 (en) | 2010-02-24 |
| CN101679385A (zh) | 2010-03-24 |
| WO2008148688A1 (en) | 2008-12-11 |
| EP2155729B1 (en) | 2011-02-16 |
| AU2008258664A8 (en) | 2010-01-14 |
| KR101163294B1 (ko) | 2012-07-05 |
| JP2010529068A (ja) | 2010-08-26 |
| ES2359598T3 (es) | 2011-05-25 |
| US7501422B2 (en) | 2009-03-10 |
| CA2690292A1 (en) | 2008-12-11 |
| AU2008258664A1 (en) | 2008-12-11 |
| KR20100020026A (ko) | 2010-02-19 |
| MX2009013116A (es) | 2010-01-15 |
| ATE498622T1 (de) | 2011-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0812447A2 (pt) | Derivados de prolinamida como antagonistas de nk3 | |
| PH12015502001A1 (en) | Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use | |
| MX2013001614A (es) | Compuestos heterociclico. | |
| MX366855B (es) | Compuestos perfluorados de 5,6-dihidro-4h-1,3-oxazin-2-amina como inhibidores de beta-secretasa y metodos de uso. | |
| MA32898B1 (fr) | Modulateurs allosteriques positifs du recepteur m1 d'arylmethylbenzoquinazolinone | |
| PE20121640A1 (es) | Derivados de pirazina como inhibidores de bace | |
| ATE438632T1 (de) | Aryl-4-ethinylisoxazolderivate | |
| DE602006010540D1 (de) | (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl)-amine mit aktivität am 5-ht-rezeptor | |
| MX2010002899A (es) | Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de la histamina-3. | |
| MX2011008850A (es) | Derivados de piperidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| MA32943B1 (fr) | Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique | |
| PH12015500398A1 (en) | Ethynyl derivatives as modulators of mglur5 receptor activity | |
| MX2012001799A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinona 3 (nk3). | |
| PH12015502692B1 (en) | Ethynyl derivatives as metabotropic glutamate receptor antagonists | |
| BRPI0916657A2 (pt) | pirrolidin-3-ilmetil-amina como antagonistas de orexina | |
| BR112012014576A2 (pt) | derivados de pirrolidina como antagonistas do receptor nk-3 | |
| UA114008C2 (xx) | Похідні етинілу як модулятори активності рецептора mglur5 | |
| MX2011008178A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| ATE546455T1 (de) | Spiropiperidinderivate als nk3-antagonisten | |
| BRPI0812253A2 (pt) | Derivados de prolinamida-tetrazol como antagonistas do receptor nk-3 | |
| BRPI0816971A2 (pt) | Derivados de piperidina como antagonistas de receptor nk3 | |
| DE602007012683D1 (de) | Substituierte Tetrahydro-Chinolinsulfonamidverbindungen, ihre Herstellung und ihre Verwendung als Medikamente | |
| BRPI0606730A2 (pt) | derivados de fenil metanona 2,5-di-substituìdos como inibidores do transportador de glicina 1 (glyt-1) para o tratamento de distúbios neurológicos e neuropsiquiátricos | |
| BRPI0712608A8 (pt) | oxindoldioxanos, síntese dos mesmos e intermediários dos mesmos | |
| ATE487704T1 (de) | Substituierte triazolderivate und ihre verwendung als antagonisten des neurokinin-3-rezeptors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |